Please assess the completion status of the following clinical trial:

Trial Title: Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 1 or type 2 diabetes~* Diabetic retinopathy~* Age 18-70~* Both sexes~Exclusion Criteria:~* Age \<18 or \>70 at enrollment~* Hereditary muscle disorders~* Uncontrolled hypothyroidism~* Elevated alcohol consumption~* Renal failure~* Hepatic failure~* Allergy to fenofibrate or excipients~* Acute / chronic pancreatitis~* Pregnancy and lactation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Fenofibrate (Type: EXPERIMENTAL): Fenofibrate 145 mg (Fulcrosupra) oral tablets daily for 12 weeks
- Placebo (Type: PLACEBO_COMPARATOR): Placebo oral tablets daily for 12 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).